Literature DB >> 8397718

Predominance of IgG1 subclass of anti-Ro/SSA, but not anti-La/SSB antibodies in primary Sjögren's syndrome.

R Maran1, M Dueymes, Y L Pennec, R Casburn-Budd, Y Shoenfeld, P Youinou.   

Abstract

We have developed isotype-specific enzyme-linked immunosorbent assays to assess anti-Ro/SSA and anti-La/SSB IgG subclasses in 31 patients with primary Sjögren's syndrome. The anti-Ro/SSA antibody production was largely but not totally restricted to IgG1, whilst the anti-La/SSB subclass distribution varied from one patient to another. IgG2 and IgG3 anti-La/SSB was more frequent in those patients with extraglandular manifestations. In addition, there were more increases in the IgG2 and IgG4 contribution to anti-La/SSB activity in the 16 DR3-positive patients than in the remaining 10.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397718     DOI: 10.1006/jaut.1993.1032

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  7 in total

1.  Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6.NOD-Aec1Aec2 mice is dependent on complement component-3.

Authors:  Cuong Q Nguyen; Hyuna Kim; Janet G Cornelius; Ammon B Peck
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

Review 2.  Anti-Ro(SSA) and anti-La(SSB) antibodies in autoimmune rheumatic diseases.

Authors:  P Youinou; Y Adler; S Muller; A Lamour; D Baron; R L Humbel
Journal:  Clin Rev Allergy       Date:  1994

3.  IL-4-STAT6 signal transduction-dependent induction of the clinical phase of Sjögren's syndrome-like disease of the nonobese diabetic mouse.

Authors:  Cuong Q Nguyen; Jue-hua Gao; Hyuna Kim; Daniel R Saban; Janet G Cornelius; Ammon B Peck
Journal:  J Immunol       Date:  2007-07-01       Impact factor: 5.422

4.  Isotypic distribution of anti-pyruvate dehydrogenase antibodies in patients with primary biliary cirrhosis and their family members.

Authors:  R Maran; M Dueymes; Y Adler; Y Shoenfeld; P Youinou
Journal:  J Clin Immunol       Date:  1994-09       Impact factor: 8.317

5.  Early BAFF receptor blockade mitigates murine Sjögren's syndrome: Concomitant targeting of CXCL13 and the BAFF receptor prevents salivary hypofunction.

Authors:  Arjun Sharma; Jeremy Kiripolsky; Ekaterina Klimatcheva; Alan Howell; Farzad Fereidouni; Richard Levenson; Thomas L Rothstein; Jill M Kramer
Journal:  Clin Immunol       Date:  2016-01-28       Impact factor: 3.969

6.  Screening for IgG4-type anti-nuclear antibodies in IgG4-related disease.

Authors:  Kazuhiro Kiyama; Hajime Yoshifuji; Tsugumitsu Kandou; Yuji Hosono; Koji Kitagori; Ran Nakashima; Yoshitaka Imura; Naoichiro Yukawa; Koichiro Ohmura; Takao Fujii; Daisuke Kawabata; Tsuneyo Mimori
Journal:  BMC Musculoskelet Disord       Date:  2015-05-28       Impact factor: 2.362

7.  Identification of possible candidate genes regulating Sjögren's syndrome-associated autoimmunity: a potential role for TNFSF4 in autoimmune exocrinopathy.

Authors:  Cuong Q Nguyen; Janet G Cornelius; Lauren Cooper; Jonathan Neff; Joann Tao; Byung Ha Lee; Ammon B Peck
Journal:  Arthritis Res Ther       Date:  2008-11-25       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.